Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 67,325 | 72,135 | 74,291 | 76,887 | 6,227 |
| TOTAL | $68,858 | $73,557 | $75,632 | $78,636 | $7,934 |
| Non-Current Assets | |||||
| PPE Net | 101 | 115 | 132 | 156 | 174 |
| Other Non-Current Assets | 1,406 | 1,449 | 1,491 | 262 | 302 |
| TOTAL | $1,507 | $1,564 | $1,623 | $418 | $476 |
| Total Assets | $70,365 | $75,121 | $77,255 | $79,054 | $8,410 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 524 | 1,255 | 568 | 621 | 886 |
| Accrued Expenses | 2,906 | 1,730 | 1,334 | 1,204 | 1,793 |
| TOTAL | $3,554 | $3,160 | $2,098 | $2,122 | $2,966 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,405 | 1,401 | 1,426 | 107 | 13,007 |
| TOTAL | $1,403 | $1,401 | $1,426 | $108 | $12,984 |
| Total Liabilities | $4,957 | $4,561 | $3,524 | $2,230 | $15,950 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 634 | 528 | 528 | 528 | 519 |
| Common Shares | 13 | 132 | 132 | 132 | 29 |
| Retained earnings | -271,284 | -266,021 | -262,748 | -259,553 | -248,094 |
| Other shareholders' equity | 0 | -2,774 | -2,774 | -2,774 | -296 |
| TOTAL | $65,408 | $70,560 | $73,731 | $76,824 | $-7,540 |
| Total Liabilities And Equity | $70,365 | $75,121 | $77,255 | $79,054 | $8,410 |